Compare UK prices. 40+ products · 22 retailers scored
PeptideClear UK

Editorial · Wellness · IV therapy

Immune IV drip UK: vitamin C dosing in context

OM

Oliver Mackman · Editorial director · Best Business Loans Ltd (16833937)

Published Tue Jun 02 2026 01:00:00 GMT+0100 (British Summer Time) · 6 min read

An immune IV drip is a high-dose vitamin C infusion, often paired with zinc and B vitamins, marketed by UK wellness clinics as support during cold and flu seasons. It is sold as a private wellness service, not a UK licensed medicine, under CQC and prescriber regulation. The marketing outruns the evidence: high-dose vitamin C does not reliably prevent colds in the general population, and most healthy people meet their vitamin C needs easily through diet. Anyone unwell or worried about their immune health should speak to their GP rather than relying on a drip.

The immune drip is the cold-and-flu-season product of the IV wellness world, built around high-dose vitamin C. This post explains what is in it, the dosing question, how it is regulated, and why the marketing tends to outrun the evidence. It is editorial commentary. We do not sell drips or recommend one for any individual.

What is in an immune drip

An immune drip is usually a saline base with a high dose of vitamin C, often paired with zinc and B vitamins. The doses of vitamin C used intravenously can be far higher than anything achievable from food or oral supplements, because the IV route bypasses the gut’s absorption limit. That high-dose framing is the main selling point, and it is also where the safety and evidence questions concentrate.

It is worth separating two things the marketing tends to merge. Vitamin C is genuinely required for immune function, and a true deficiency (scurvy) impairs it. But for someone who already gets enough vitamin C, which is most people in the UK, adding more does not give the immune system an extra gear. Sufficiency is the relevant threshold, not maximisation.

The high-dose vitamin C question

High-dose intravenous vitamin C has been studied in specific medical contexts, including some oncology supportive-care research, under hospital supervision. That is a regulated medical setting with monitoring, and it is not the same thing as a wellness clinic immune drip. Importing the existence of that research into a cold-and-flu marketing claim is a stretch the evidence does not justify.

There are also reasons for caution at high doses. Very high intravenous vitamin C is not appropriate for everyone, and certain conditions make it unsafe, which is one reason a proper prescriber assessment matters. A drip is not a casual purchase, and the dose is exactly why. We weigh the route generally in IV drip vs oral supplement.

How it is regulated

The immune drip is not a UK licensed medical treatment. It is a private wellness service under CQC registration of the clinic in England (or the devolved-nation equivalent), with a GMC- or GPhC-registered prescriber and a qualified clinician placing the line. The IV therapy hub lists these trust signals in full, and the clinics keep their advertising inside ASA and CAP rules by avoiding explicit disease claims.

What the evidence says

The evidence that an immune drip prevents or shortens colds in healthy adults is limited. The broader vitamin C literature shows that routine supplementation does not reliably prevent colds in the general population, and a single seasonal infusion is even less likely to change long-term immune status. The marketing leans on the plausible idea that more vitamin C means more immunity; the data does not support that once a person is already getting enough.

The honest summary is that the immune drip is a paid wellness service whose cold-and-flu positioning runs ahead of the evidence. Most healthy people meet their vitamin C needs through diet. Anyone who is genuinely unwell, or worried about recurrent infections, should speak to their GP, because that pattern deserves a clinical assessment rather than a drip.

See vitamin IV drip UK for the standard offer, IV drip cost in the UK for prices, and the IV therapy hub for the full landscape.

PeptideClear is editorial commentary, not clinical advice. We do not sell, prescribe, or recommend a specific supplement, dose, or clinic for a specific person. NAD+, NMN and NR are sold in the UK as food supplements. Decisions about supplements or private clinical services are between you and a suitably qualified healthcare professional.

Read our full methodology and how we are funded.

Reviewed by Oliver Mackman, editorial director · last reviewed Tue Jun 02 2026 01:00:00 GMT+0100 (British Summer Time)
Trust, Legal and Governance

PeptideClear is a trading name of Best Business Loans Ltd, registered in England and Wales (company number 16833937). All services, operations and publications under the PeptideClear brand are delivered by Best Business Loans Ltd.

Legal and Registration

Registered in England and Wales. Company number 16833937. D‑U‑N‑S 234324824. ICO registered, reference ZC151816 (certificate, verify). Registered supplier on the UK Government's Find a Tender Service (FTS). Details publicly available via Companies House and OpenCorporates.

Standards and Governance

Operates under UK data protection and consumer standards. Aligns with UK GDPR, ISO 27001 and ISO 9001 principles. Working towards Cyber Essentials certification.

Domain Continuity

Primary domain peptideclear.co.uk. Business ownership, entity and services remain unchanged. Reviewed quarterly.